6ARK
Crystal Structure of compound 10 covalently bound to K-Ras G12C
Summary for 6ARK
Entry DOI | 10.2210/pdb6ark/pdb |
Descriptor | GTPase KRas, GUANOSINE-5'-DIPHOSPHATE, MAGNESIUM ION, ... (6 entities in total) |
Functional Keywords | dockovalent, covalent docking, k-ras g12c, covalent inhibitors, covalent fragments, signaling protein, signaling protein-inhibitor complex, signaling protein/inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 20395.74 |
Authors | Nnadi, C.I.,Jenkins, M.L.,Gentile, D.R.,Bateman, L.A.,Zaidman, D.,Balius, T.E.,Nomura, D.K.,Burke, J.E.,Shokat, K.M.,London, N. (deposition date: 2017-08-22, release date: 2018-01-31, Last modification date: 2024-10-16) |
Primary citation | Nnadi, C.I.,Jenkins, M.L.,Gentile, D.R.,Bateman, L.A.,Zaidman, D.,Balius, T.E.,Nomura, D.K.,Burke, J.E.,Shokat, K.M.,London, N. Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange. J Chem Inf Model, 58:464-471, 2018 Cited by PubMed Abstract: The success of targeted covalent inhibitors in the global pharmaceutical industry has led to a resurgence of covalent drug discovery. However, covalent inhibitor design for flexible binding sites remains a difficult task due to a lack of methodological development. Here, we compared covalent docking to empirical electrophile screening against the highly dynamic target K-Ras. While the overall hit rate of both methods was comparable, we were able to rapidly progress a docking hit to a potent irreversible covalent binder that modifies the inactive, GDP-bound state of K-Ras. Hydrogen-deuterium exchange mass spectrometry was used to probe the protein dynamics of compound binding to the switch-II pocket and subsequent destabilization of the nucleotide-binding region. SOS-mediated nucleotide exchange assays showed that, contrary to prior switch-II pocket inhibitors, these new compounds appear to accelerate nucleotide exchange. This study highlights the efficiency of covalent docking as a tool for the discovery of chemically novel hits against challenging targets. PubMed: 29320178DOI: 10.1021/acs.jcim.7b00399 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report